Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesalazine induced interstitial nephritis

P J Thuluvath1, M Ninkovic, J Calam

  • 1West Middlesex University Hospital, Isleworth.

Gut
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lectins: from basic science to clinical application in cancer prevention.

Expert opinion on investigational drugs·2005
Same author

Effects of Ostertagia ostertagi and omeprazole treatment on feed intake and gastrin-related responses in the calf.

Veterinary parasitology·2002
Same author

ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer.

BMJ (Clinical research ed.)·2001
Same author

Comparison of the effects of concanavalin-A and epidermal growth factor on epithelial cell proliferation in the rat intestine.

Alimentary pharmacology & therapeutics·2001
Same author

Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist.

Gut·2001
Same author

Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C.

Gut·2001
Same journal

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Gut·2026
Same journal

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Gut·2026
Same journal

USP20 promotes CD8<sup>+</sup> T cell exhaustion and impairs KRAS<sup>G12D</sup> inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.

Gut·2026
Same journal

CTCF-rs705704-SUOX axis is important for the association between hypothyroidism and metabolic dysfunction-associated steatotic liver disease.

Gut·2026
Same journal

<i>Helicobacter pylori</i> infection, treatment and colorectal cancer risk by genetic predisposition: evidence from two randomised trials.

Gut·2026
Same journal

Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.

Gut·2026
See all related articles

Severe kidney damage, known as interstitial nephritis, can occur from 5-Aminosalicylic acid (5-ASA) use. Monitoring kidney function is crucial for patients with inflammatory bowel disease on 5-ASA medications.

Area of Science:

  • Nephrology
  • Pharmacology
  • Gastroenterology

Background:

  • 5-Aminosalicylic acid (5-ASA) is increasingly utilized for inflammatory bowel diseases.
  • Structural similarities exist between 5-ASA, phenacetin, and aspirin, both linked to analgesic nephropathy.

Observation:

  • Two cases of severe interstitial nephritis attributed to 5-ASA are presented.
  • These cases highlight a potential adverse renal effect of 5-ASA therapy.

Findings:

  • 5-ASA can induce severe interstitial nephritis, a serious kidney condition.
  • The mechanism may involve hypersensitivity or direct toxicity, similar to other NSAIDs.

Implications:

  • Clinicians should consider 5-ASA as a potential cause of acute kidney injury.

Related Experiment Videos

  • Regular renal function monitoring is essential for inflammatory bowel disease patients on 5-ASA.
  • Early detection and cessation of 5-ASA may prevent irreversible renal damage.